Shopping Cart

The shopping cart is empty

View courses and libraries and add them to the cart

{{item.title}} {{item.ceu}} hour {{item.ceu}} hours {{item.price | currency}} {{ getItemDiscountedPrice(item.price, item.discountedAmount) | currency}} {{item.priceAdjusted | currency}}

{{item.title}} {{item.price | currency}} {{ getItemDiscountedPrice(item.price, item.discountedAmount) | currency}} {{item.priceAdjusted | currency}}

Customers who Purchased
this Activity also Purchased

PREMIUM

{{recommendationsA.Title}}

Article
{{recommendationsA.Ceu}} hour | {{recommendationsA.Price | currency}} Article
{{recommendationsA.Ceu}} hours | {{recommendationsA.Price | currency}} {{recommendationsA.Price | currency}}

{{recommendationsA.Type}} {{recommendationsA.Type}}

PREMIUM

{{recommendationsB.Title}}

Article
{{recommendationsB.Ceu}} hour | {{recommendationsB.Price | currency}} Article
{{recommendationsB.Ceu}} hours | {{recommendationsB.Price | currency}} {{recommendationsA.Price | currency}}

{{recommendationsB.Type}} {{recommendationsB.Type}}

Total

{{totalCEUs}} hour{{totalCEUs}} hours

{{cart.total_amount | currency}}

@media (max-width: 991px) { body { padding-top: 0; } .site-header { height: auto; min-height: 65px; } .site-header.fixed-top { position: relative; } .site-header .container-fluid { flex-flow: row wrap; } .nav-site-toggle { display: none; } .site-logo { position: static; top:auto; left:auto; transform: none; margin: 10px auto; order: 1; } .nav-site { width: 100%; position: static; overflow: visible; background-color: #ffffff; order: 3; } .nav-site-close { display: none; } .nav-site .nav-site-menu { width: 100%; height: auto; margin-left: 0; overflow: visible; } .nav-site .nav-item .dropdown-toggle::after{ display: none; } .nav-site .navbar-nav { margin: 0; padding: 0; position: relative; overflow: visible; overflow-y: visible; height: auto; } .nav-site .nav-breadcrumb { display: none; } .nav-site .nav-item .dropdown-toggle { background-color: #e1e1e1; text-transform: uppercase; } .nav-site .nav-item .dropdown-menu { position: static; margin: 0; } .nav-site .nav-site-menu .navbar-nav .nav-item.dropdown-resources { font-weight: bold; background-color: #F2F4F6; } .nav-user { order: 2; margin: 0 10px 10px 10px; width: 100%; text-align: center; } .nav-user .user-menu { flex-flow: row wrap; } .nav-user .user-menu .user-menu-toggle { } .nav-user .user-menu .dropdown-menu { display: block; width: 100% !important; position: static; float: none; } .nav-user .user-menu .dropdown-menu::before, .nav-user .user-menu .dropdown-menu::after { display: none; } } @media (min-width: 992px) { body { padding-top: 0; } .site-header { height: auto; min-height: 65px; margin-bottom: 500px; } .site-header.fixed-top { position: static; } .nav-site .nav-site-menu .navbar-nav .nav-item:hover > .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item:focus-within > .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.super { display: flex; flex-flow: row nowrap; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm1 { left: -376%; padding-right: 20px; width: 548px; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm1:before { left: 80%; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm1:after { left: 80.2%; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm2 { left: 44%; padding-right: 20px; min-width: 6rem; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm2 .dropdown-item { min-width: 170px; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm2:before { left: 5%; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm2:after { left: 5.2%; } .nav-site .nav-site-menu .navbar-nav .nav-item.dropdown-resources { } .nav-user .user-menu .dropdown-menu { display: block; left: -20px; width: 210px !important; } .nav-user .user-menu .dropdown-menu .dropdown-item { min-width: 170px; } } .card-slider { overflow-x: auto; }

1. Which of the following best approximates the prevalence of COVID-19 antibodies in U.S. residents?

A. 30% B. 50% C. 75% D. 95%

2. In a recent study evaluating ritonavir-boosted nirmatrelvir in a younger vaccinated population, which of the following outcomes was not affected positively?

A. Hospitalizations B. Death C. Constitutional symptoms D. Taste/smell alterations

3. Which of the following antiviral agents for COVID-19 requires renal dose adjustment when the estimated GFR is less than 60 mL/min?

A. Ritonavir-boosted nirmatrelvir B. Remdesivir C. Molnupiravir D. Acyclovir

4. As a treatment modality for COVID-19, vilobelimab is best described as a(n)

A. Antiviral agent for mild-to-moderate COVID-19 in the ambulatory setting B. Monoclonal antibody for mild-to-moderate COVID-19 in the ambulatory setting C. Antiviral agent for severe COVID-19 in the hospitalized setting D. Monoclonal antibody for severe COVID-19 in the hospitalized setting

5. In which of the following study populations did remdesivir decrease 14- and 28-day mortality compared with usual care?

A. Pediatric hospitalized patients B. Immunocompromised ambulatory patients C. Immunocompromised hospitalized patients D. Obese immunocompetent hospitalized patients

6. Which of the following benefits was demonstrated with a 14-day course of metformin in the management of COVID-19?

A. Decreased risk of initial hospitalization B. Decreased risk of mortality C. Decreased risk of long COVID D. Decreased risk of readmission after initial hospitalization

7. Presence of HLA-B*15:01 is associated with which of the following COVID-19–related outcomes?

A. Decreased mortality B. Decreased risk of hospitalization C. Decreased presence of symptoms D. Increased risk of anosmia

8. Lower antibody titers have been demonstrated when which of the following vaccine pairs are coadministered?

A. COVID-19 booster plus influenza vaccine B. COVID-19 booster plus RSV vaccine C. COVID-19 booster plus zoster vaccine D. RSV vaccine plus influenza vaccine

9. Which of the following best describes the omicron variant XBB.1.5?

A. XBB.1.5 is currently the most prevalent variant in circulation in the United States B. XBB.1.5 is the variant the FDA recommended in the spring for inclusion in fall 2023 booster shots C. XBB.1.5 increases the risk of hospitalization compared with previous variants D. XBB.1.5 increases the risk of anosmia compared with previous variants

10. Which of the following statements is true regarding COVID-19 and dysgeusia?

A. Dysgeusia induced by ritonavir-boosted nirmatrelvir tends to persist for months after cessation of other symptoms. B. COVID-19–induced dysgeusia occurs primarily in pediatric patients. C. Dysgeusia induced by ritonavir-boosted nirmatrelvir is related primarily to treatment with nirmatrelvir. D. SARS-CoV-2 has been found in biopsies of patients with long-term dysgeusia following COVID-19.

Evaluation Questions

11. To what extent did the program meet objective #1?

A. Excellent B. Very Good C. Good D. Fair E. Poor

12. To what extent did the program meet objective #2?

A. Excellent B. Very Good C. Good D. Fair E. Poor

13. Rate the effectiveness of how well the program related to your educational needs:

A. Excellent B. Very Good C. Good D. Fair E. Poor

14. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:

A. Excellent B. Very Good C. Good D. Fair E. Poor

15. Rate the quality of the faculty:

A. Excellent B. Very Good C. Good D. Fair E. Poor

16. Rate the effectiveness and the overall usefulness of the material presented:

A. Excellent B. Very Good C. Good D. Fair E. Poor

17. Rate the appropriateness of the examination for this activity:

A. Excellent B. Very Good C. Good D. Fair E. Poor

18. Rate the effectiveness of how well the activity related to your practice needs:

A. Excellent B. Very Good C. Good D. Fair E. Poor

19. Rate the effectiveness of how well the activity will help you improve patient care:

A. Excellent B. Very Good C. Good D. Fair E. Poor

20. Will the information presented cause you to change your practice?

A. Yes B. No

21. Are you committed to making these changes?

A. Yes B. No

22. As a result of this activity, did you learn something new?

A. Yes B. No

23. What is your practice setting or area of practice?

A. Community Pharmacy/Independent B. Community Pharmacy/Chain C. Hospital/Health Systems D. Administrative/Pharmacy Director E. Critical Care Pharmacy F. Long-term Care G. Managed Care/PBM H. Oncology I. Specialty Pharmacy J. Industry/Manufacturing

24. How many years have you been in practice?

A. <5 B. 5 – 10 C. 11 – 20 D. >20

« Return to Activity